News
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients Outside the Defined Criteria
While the use of recombinant tissue plasminogen activator in accordance to licensed criteria has continuously risen, off-label use is also frequent. In this review the most important reasons to ...
A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results